List of works - Karen Cohen

A Clinical Prediction Rule for Protease Inhibitor Resistance in Patients Failing Second-Line Antiretroviral Therapy

scientific article published on 01 March 2019

A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy

scientific article published on 24 July 2015

A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa

scientific article published on 29 September 2017

A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis

scientific article published on 05 August 2019

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

scientific article published in 2023

AGREE to disagree: critical appraisal and the publication of practice guidelines

scientific article

Abdominal Ultrasound for the Diagnosis of Tuberculosis Among Human Immunodeficiency Virus-Positive Inpatients With World Health Organization Danger Signs

article

Acute interstitial nephritis caused by lopinavir/ritonavir in a surgeon receiving antiretroviral postexposure prophylaxis

scientific article

Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa

scientific article published on May 2016

Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports

scientific article published on 7 November 2015

Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

scientific article published on 20 June 2019

Analysis of queries from nurses to the South African National HIV & TB Health Care Worker Hotline

article

Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans

scientific article published on 3 December 2015

Antiretroviral therapy and early mortality in South Africa

scientific article published on September 2008

Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa

scientific article

Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir

scientific article

Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?

scientific article published on 04 April 2017

Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?

scientific article

Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy

scientific article published on 4 May 2016

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis

scientific article published on 19 December 2007

Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries

scientific article published on January 2009

First-line antiretroviral drug discontinuations in children

scientific article

How good are our guidelines? Four years of experience with the SAMJ's AGREE II review of submitted clinical practice guidelines

scientific article published on 26 October 2018

Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics

scientific article

Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

scientific article published on 26 September 2011

Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.

scientific article

Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen

scientific article

Management of individuals requiring antiretroviral therapy and TB treatment

scientific article published on January 2010

Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey

scientific article

N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol

scientific article

N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.

scientific article published on 12 January 2016

NeuroAIDS in children.

scientific article published in January 2018

Nevirapine concentrations in preterm and low birth weight HIV-exposed infants: implications for dosing recommendations

scientific article published in December 2014

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy

scientific article

Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa

scientific article published on 25 May 2018

Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

scientific article

Provision of antiretroviral therapy in South Africa: the nuts and bolts

scientific article

Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy

scientific article published on 9 June 2016

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

scientific article published on March 2016

Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts

scientific article published in PLoS ONE

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections

scientific article

Safety implications of combined antiretroviral and anti-tuberculosis drugs

scientific article published on 06 December 2019

Serious adverse drug reactions at two children's hospitals in South Africa

scientific article published on 04 January 2020

Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis

scientific article published on 27 July 2016

Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia

scientific article

Strengthening pharmacovigilance in South Africa

article

Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction ⬇️

scientific article published on May 28, 2013

The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children

scientific article

The impact of the National HIV Health Care Worker Hotline on patient care in South Africa

scientific article

The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients

scientific article published on 27 January 2016

The role of rilpivirine in Southern Africa

scientific article published on 29 May 2019

Therapeutic drug monitoring of antiretrovirals for people with HIV

scientific article

Therapeutic drug monitoring of antiretrovirals for people with HIV

scientific article (published 2008-07-16)

Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch

scientific article published on 13 August 2013

List of works by Karen Cohen

A Clinical Prediction Rule for Protease Inhibitor Resistance in Patients Failing Second-Line Antiretroviral Therapy

A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy

A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa

A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

AGREE to disagree: critical appraisal and the publication of practice guidelines

Abdominal Ultrasound for the Diagnosis of Tuberculosis Among Human Immunodeficiency Virus-Positive Inpatients With World Health Organization Danger Signs

Acute interstitial nephritis caused by lopinavir/ritonavir in a surgeon receiving antiretroviral postexposure prophylaxis

Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa

Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports

Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

Analysis of queries from nurses to the South African National HIV & TB Health Care Worker Hotline

Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans

Antiretroviral therapy and early mortality in South Africa

Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa

Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir

Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?

Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?

Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis

Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries

First-line antiretroviral drug discontinuations in children

How good are our guidelines? Four years of experience with the SAMJ's AGREE II review of submitted clinical practice guidelines

Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics

Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.

Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen

Management of individuals requiring antiretroviral therapy and TB treatment

Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey

N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol

N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.

NeuroAIDS in children.

Nevirapine concentrations in preterm and low birth weight HIV-exposed infants: implications for dosing recommendations

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy

Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa

Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

Provision of antiretroviral therapy in South Africa: the nuts and bolts

Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections

Safety implications of combined antiretroviral and anti-tuberculosis drugs

Serious adverse drug reactions at two children's hospitals in South Africa

Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis

Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia

Strengthening pharmacovigilance in South Africa

Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction ⬇️

The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children

The impact of the National HIV Health Care Worker Hotline on patient care in South Africa

The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients

The role of rilpivirine in Southern Africa

Therapeutic drug monitoring of antiretrovirals for people with HIV

Therapeutic drug monitoring of antiretrovirals for people with HIV

Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch